0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      CGG repeats trigger translational frameshifts that generate aggregation-prone chimeric proteins

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          CGG repeat expansions in the FMR1 5’UTR cause the neurodegenerative disease Fragile X-associated tremor/ataxia syndrome (FXTAS). These repeats form stable RNA secondary structures that support aberrant translation in the absence of an AUG start codon (RAN translation), producing aggregate-prone peptides that accumulate within intranuclear neuronal inclusions and contribute to neurotoxicity. Here, we show that the most abundant RAN translation product, FMRpolyG, is markedly less toxic when generated from a construct with a non-repetitive alternating codon sequence in place of the CGG repeat. While exploring the mechanism of this differential toxicity, we observed a +1 translational frameshift within the CGG repeat from the arginine to glycine reading frame. Frameshifts occurred within the first few translated repeats and were triggered predominantly by RNA sequence and structural features. Short chimeric R/G peptides form aggregates distinct from those formed by either pure arginine or glycine, and these chimeras induce toxicity in cultured rodent neurons. Together, this work suggests that CGG repeats support translational frameshifting and that chimeric RAN translated peptides may contribute to CGG repeat-associated toxicity in FXTAS and related disorders.

          Related collections

          Most cited references78

          • Record: found
          • Abstract: found
          • Article: not found

          Oligoribonucleotide synthesis using T7 RNA polymerase and synthetic DNA templates.

          A method is described to synthesize small RNAs of defined length and sequence using T7 RNA polymerase and templates of synthetic DNA which contain the T7 promoter. Partially single stranded templates which are base paired only in the -17 to +1 promoter region are just as active in transcription as linear plasmid DNA. Runoff transcripts initiate at a unique, predictable position, but may have one nucleotide more or less on the 3' terminus. In addition to the full length products, the reactions also yield a large amount of smaller oligoribonucleotides in the range from 2 to 6 nucleotides which appear to be the result of abortive initiation events. Variants in the +1 to +6 region of the promoter are transcribed with reduced efficiency but increase the variety of RNAs which can be made. Transcription reaction conditions have been optimized to allow the synthesis of milligram amounts of virtually any RNA from 12 to 35 nucleotides in length.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            RNA Phase Transitions in Repeat Expansion Disorders

            Expansions of short nucleotide repeats produce several neurological and neuromuscular disorders including Huntington’s disease, muscular dystrophy and amyotrophic lateral sclerosis. A common pathological feature of these diseases is the accumulation of the repeat containing transcripts into aberrant foci in the nucleus. RNA foci, as well as the disease symptoms, only manifest above a critical number of nucleotide repeats, but the molecular mechanism governing foci formation above this characteristic threshold remains unresolved. Here, we show that repeat expansions create templates for multivalent base-pairing, which causes purified RNA to undergo a sol-gel transition at a similar critical repeat number as observed in the diseases. In cells, RNA foci form by phase separation of the repeat-containing RNA and can be dissolved by agents that disrupt RNA gelation in vitro. Analogous to protein aggregation disorders, our results suggest that the sequence-specific gelation of RNAs could be a contributing factor to neurological disease.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              CGG repeat-associated translation mediates neurodegeneration in fragile X tremor ataxia syndrome.

              Fragile X-associated tremor ataxia syndrome (FXTAS) results from a CGG repeat expansion in the 5' UTR of FMR1. This repeat is thought to elicit toxicity as RNA, yet disease brains contain ubiquitin-positive neuronal inclusions, a pathologic hallmark of protein-mediated neurodegeneration. We explain this paradox by demonstrating that CGG repeats trigger repeat-associated non-AUG-initiated (RAN) translation of a cryptic polyglycine-containing protein, FMRpolyG. FMRpolyG accumulates in ubiquitin-positive inclusions in Drosophila, cell culture, mouse disease models, and FXTAS patient brains. CGG RAN translation occurs in at least two of three possible reading frames at repeat sizes ranging from normal (25) to pathogenic (90), but inclusion formation only occurs with expanded repeats. In Drosophila, CGG repeat toxicity is suppressed by eliminating RAN translation and enhanced by increased polyglycine protein production. These studies expand the growing list of nucleotide repeat disorders in which RAN translation occurs and provide evidence that RAN translation contributes to neurodegeneration. Copyright © 2013 Elsevier Inc. All rights reserved.
                Bookmark

                Author and article information

                Contributors
                Journal
                Nucleic Acids Res
                Nucleic Acids Res
                nar
                Nucleic Acids Research
                Oxford University Press
                0305-1048
                1362-4962
                26 August 2022
                29 July 2022
                29 July 2022
                : 50
                : 15
                : 8674-8689
                Affiliations
                Department of Neurology, University of Michigan , Ann Arbor, MI 48109, USA
                Neuroscience Graduate Program, University of Michigan , Ann Arbor, MI 48109, USA
                Department of Neurology, University of Michigan , Ann Arbor, MI 48109, USA
                Neuroscience Graduate Program, University of Michigan , Ann Arbor, MI 48109, USA
                Department of Genetics, Stanford University School of Medicine , Stanford, CA 84305, USA
                Department of Chemistry, University of Michigan , Ann Arbor, MI 48109, USA
                Department of Neurology, University of Michigan , Ann Arbor, MI 48109, USA
                Department of Neurology, University of Michigan , Ann Arbor, MI 48109, USA
                VA Ann Arbor Healthcare System , Ann Arbor, MI 48105, USA
                Department of Neurology, University of Michigan , Ann Arbor, MI 48109, USA
                Cellular and Molecular Biology Graduate Program, University of Michigan , Ann Arbor, MI 48109, USA
                Department of Pathology, University of Michigan , Ann Arbor, MI 48109, USA
                Department of Neurology, University of Michigan , Ann Arbor, MI 48109, USA
                Biophysics Program, University of Michigan , Ann Arbor, MI 48109, USA
                Department of Chemistry, University of Michigan , Ann Arbor, MI 48109, USA
                Department of Neurology, University of Michigan , Ann Arbor, MI 48109, USA
                Department of Neurology, University of Michigan , Ann Arbor, MI 48109, USA
                VA Ann Arbor Healthcare System , Ann Arbor, MI 48105, USA
                Author notes
                To whom correspondence should be addressed. Tel: +1 734 625 5632; Fax: +1 734 647 9777; Email: petertod@ 123456umich.edu
                Author information
                https://orcid.org/0000-0003-4781-6376
                Article
                gkac626
                10.1093/nar/gkac626
                9410890
                35904811
                01c9cd2b-c294-4b2f-9410-47481551cff8
                © The Author(s) 2022. Published by Oxford University Press on behalf of Nucleic Acids Research.

                This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 13 July 2022
                : 03 June 2022
                Page count
                Pages: 16
                Funding
                Funded by: NIH, DOI 10.13039/100000002;
                Award ID: P50HD104463
                Award ID: R01NS099280
                Award ID: R01NS086810
                Award ID: T32-NS076401
                Award ID: NRSA F31NS113513
                Award ID: F32NS116208
                Award ID: R01NS096785
                Award ID: R35GM128836
                Funded by: VA, DOI 10.13039/100000738;
                Award ID: BLRD BX004842
                Categories
                AcademicSubjects/SCI00010
                Molecular Biology

                Genetics
                Genetics

                Comments

                Comment on this article